KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Current Deferred Revenue: 2015-2024

  • Nu Skin Enterprises' Current Deferred Revenue fell 22.86% to $15.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was $15.7 million, marking a year-over-year decrease of 22.86%. This contributed to the annual value of $15.7 million for FY2024, which is 22.86% down from last year.
  • Latest data reveals that Nu Skin Enterprises reported Current Deferred Revenue of $15.7 million as of Q4 2024, which was down 22.86% from $20.3 million recorded in Q4 2023.
  • In the past 5 years, Nu Skin Enterprises' Current Deferred Revenue registered a high of $35.1 million during Q4 2020, and its lowest value of $15.7 million during Q4 2024.
  • Over the past 3 years, Nu Skin Enterprises' median Current Deferred Revenue value was $20.3 million (recorded in 2023), while the average stood at $21.0 million.
  • In the last 5 years, Nu Skin Enterprises' Current Deferred Revenue spiked by 73.86% in 2020 and then decreased by 24.82% in 2023.
  • Quarterly analysis of 5 years shows Nu Skin Enterprises' Current Deferred Revenue stood at $35.1 million in 2020, then fell by 5.46% to $33.1 million in 2021, then decreased by 18.37% to $27.1 million in 2022, then decreased by 24.82% to $20.3 million in 2023, then fell by 22.86% to $15.7 million in 2024.
  • Its Current Deferred Revenue was $15.7 million in Q4 2024, compared to $20.3 million in Q4 2023 and $27.1 million in Q4 2022.